microdose glp 1 for inflammation The People v. Microdosing GLP-1's Microdosing GLP-1: A Next-Generation Approach

GLP-1R agonists were initially used to treat T2DM and soon after it was found that these drugs possess many other physiological properties, such as neuroprotection, neurotrophic, and anti-inflammatory effects, which may be useful to slow the progression of AD ( Figure 3 ) (17)

The peptide is particularly sensitive to heat, and exposure to temperatures above normal refrigeration accelerates degradation significantly

Use visual inspection as one layer of your quality control system, not as the only layer

Clinical trials show average weight loss of 15-22% body weight over 68 weeks with consistent GLP-1 therapy

34 (2): 2011 Farilla L, Bulotta A, Hirshberg B, et